Other News

Optimize EP Emerges From Stealth Mode With Launch of CaRM Cardiac Device Data Management Platform

Digital Tool Automates Workflow Processes and Enhances Data Algorithms to Efficiently Improve Patient Care January 12th, 2021 STEUBENVILLE, OH / ACCESSWIRE / January 12, 2021 / Optimize EP, a digital health company focused on transforming cardiac care by improving the current state of cardiac data management, today emerged from stealth mode […]

Mesoblast Presents Heart Failure Phase 3 Trial Results at Investor Healthcare Conference

NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that its Chief Executive Officer, Dr Silviu Itescu, today presented additional data from the landmark DREAM-HF Phase 3 trial in patients with chronic heart failure. The presentation materials […]

Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure

Cardiovascular Publication Explores the Prespecified BETonMACE Analysis on Hospitalization for Heart Failure Following Acute Coronary Syndrome CALGARY, Alberta, Jan. 12, 2021 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today the recent publication of an article titled: “Apabetalone and hospitalization for heart failure in patients following an acute […]

BioSig Conducts First Patient Cases with PURE EP(tm) System at Memorial Hospital of South Bend, Indiana

PURE EP(tm) system evaluation conducted under the leadership of Cardiologists Vinod Chauhan, M.D. and Deepak Gaba, M.D. Memorial Hospital is nationally recognized for its emphasis on innovation. Westport, CT, Jan. 12, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an […]

Verve Therapeutics Announces Data Demonstrating Durable LDL Cholesterol Lowering After a One-Time Gene Editing Treatment in Non-Human Primates

Results Validate In Vivo Liver DNA Base Editing as a Once-and-Done Approach to Treat Coronary Heart Disease by Lowering of LDL Cholesterol and PCSK9 Protein Levels Company Selects VERVE-101 as Lead Program to Treat Heterozygous Familial Hypercholesterolemia CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verve Therapeutics, a biotech company pioneering gene editing medicines to treat cardiovascular disease, […]

Impulse Dynamics Closes $60 Million Financing

Funding to Accelerate Clinical and Product Development Pipelines, Commercialization of Optimizer Smart System for Heart Failure MARLTON, N.J.–(BUSINESS WIRE)–Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with heart failure, today announced the completion of a $60 million supplemental Series D crossover financing with new […]

HD Medical at CES Introduces HealthyU ™, World’s First All-in-One Smart Remote Patient Monitor for Telehealth and Wellbeing

– HealthyU ™ monitors multiple clinical parameters, plus 7-lead ECG and stethoscope integrated into one device – – Allows the patient and provider to connect remotely through an integrated platform – SANTA CLARA, California – ( BUSINESS WIRE ) – At CES’21, HD Medical Inc. today introduces HealthyU ™, an intelligent remote patient monitoring device, in […]

Rapid Medical Announces Appointment of James Romero as President, Americas

Experienced Neurovascular Device Executive will Lead Commercialization in US, Canada and LATAM YOKNEAM, Israel & FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Rapid Medical, a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces James Romero as the company’s President, Americas. Mr. Romero will oversee the growth and […]

Biotricity Announces New Solution for Personal Heart Management with Bioheart

Bioheart comfortably and continuously monitors daily activities and provides advanced heart performance data in a user-friendly format LAS VEGAS, Jan. 11, 2021 (GLOBE NEWSWIRE) — CES – Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Bioheart, a personal heart monitor. Designed for individuals diagnosed with or at risk for cardiovascular disease, Bioheart continuously […]

OMRON Healthcare Continues to Transform the Heart Health Marketplace with New Remote Patient Monitoring Service & Digital Health Tools at CES 2021

Global heart health leader introduces VitalSight™, its first remote patient monitoring service, and previews a new app that will increase the capabilities of every OMRON connected blood pressure monitor LAKE FOREST, Ill., Jan. 11, 2021 /PRNewswire/ — OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal heart health […]